Interleukin (IL)-13 as a Marker in Pediatrics Asthma

Completed

Conditions studied: Asthma

In brief

Asthma is a very common childhood chronic illness and is generally more severe in African Americans. The investigators attempted to determine whether a specific immune marker is associated with lung function and asthma severity.

Key facts

Study ID

NCT00968305

Run by

Rush University Medical Center

People needed

19

Starts

2008-11-01

Expected to finish

2009-08-01

Last updated by the study team

2009-08-28

Who can join

Age: 8 and older, up to 15. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• African-American race, born in the U.S.
• Age 8-15 years
• Clinical diagnosis of asthma
• Subject is able to understand and follow verbal instructions in English

You may not qualify if…

• Asthma exacerbation in the 4 weeks preceding the research visit
• Oral/IV steroid use in the 4 weeks preceding the research visit
• Upper or lower respiratory tract infection in the 4 weeks preceding the research visit
• Antibiotic use in the 4 weeks preceding the research visit
• Use of a short-acting bronchodilator during the 6 hours prior to spirometry (lung function testing)
• Use of a long-acting bronchodilator during the 12 hours prior to spirometry (lung function testing)

Where it is running

• Rush University Medical Center; Clinic: University Consultants in Allergy and Immunology — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.